Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.

Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, Blais D, Janicke D, Melamed R, Mohrien K, Rozycki E, Ross CB, Klein AJ, Rali P, Teman NR, Yarboro L, Ichinose E, Sharma AM, Bartos JA, Elder M, Keeling B, Palevsky H, Naydenov S, Sen P, Amoroso N, Rodriguez-Lopez JM, Davis GA, Rosovsky R, Rosenfield K, Kabrhel C, Horowitz J, Giri JS, Tapson V, Channick R; PERT Consortium.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853037. doi: 10.1177/1076029619853037.

PMID:
31185730
2.

Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.

Baird GL, Archer-Chicko C, Barr RG, Bluemke DA, Foderaro AE, Fritz JS, Hill NS, Kawut SM, Klinger JR, Lima JAC, Mullin CJ, Ouyang P, Palevsky HI, Palmisicano AJ, Pinder D, Preston IR, Roberts KE, Smith KA, Walsh T, Whittenhall M, Ventetuolo CE.

Eur Respir J. 2018 Jun 28;51(6). pii: 1800467. doi: 10.1183/13993003.00467-2018. Print 2018 Jun.

3.

Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment.

Haw A, Palevsky HI.

Respir Med. 2018 Apr;137:191-200. doi: 10.1016/j.rmed.2018.02.020. Epub 2018 Feb 28. Review.

PMID:
29605204
4.

Prostacyclin Therapy for Pulmonary Arterial Hypertension Evolves Again With the Development of an Implantable Delivery System.

Wirth JA, Palevsky HI.

Chest. 2017 Dec;152(6):1100-1102. doi: 10.1016/j.chest.2017.07.006. No abstract available.

PMID:
29223256
5.

Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document.

Rahaghi FF, Alnuaimat HM, Awdish RLA, Balasubramanian VP, Bourge RC, Burger CD, Butler J, Cauthen CG, Chakinala MM, deBoisblanc BP, Eggert MS, Engel P, Feldman J, McConnell JW, Park M, Sager JS, Sood N, Palevsky HI.

Pulm Circ. 2017 Jul-Sep;7(3):702-711. doi: 10.1177/2045893217721695. Epub 2017 Aug 22.

6.

Slow-paced respiration therapy to treat symptoms in pulmonary arterial hypertension.

Matura LA, Fargo J, Fritz JS, Smith KA, Vaidya A, Pinder D, Archer-Chicko C, Palevsky HI, Pack AI, Sommers MS, Kawut SM.

Heart Lung. 2017 Jan - Feb;46(1):7-13. doi: 10.1016/j.hrtlng.2016.11.001. Epub 2016 Nov 22.

7.

Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.

Kawut SM, Archer-Chicko CL, DeMichele A, Fritz JS, Klinger JR, Ky B, Palevsky HI, Palmisciano AJ, Patel M, Pinder D, Propert KJ, Smith KA, Stanczyk F, Tracy R, Vaidya A, Whittenhall ME, Ventetuolo CE.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):360-368. doi: 10.1164/rccm.201605-1024OC.

8.

Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension.

Kimmig LM, Palevsky HI.

Ann Am Thorac Soc. 2016 Jun;13(6):945-54. doi: 10.1513/AnnalsATS.201512-826FR. Review.

PMID:
27058013
9.

Physical Activity and Symptoms in Pulmonary Arterial Hypertension.

Matura LA, Shou H, Fritz JS, Smith KA, Vaidya A, Pinder D, Archer-Chicko C, Dubow D, Palevsky HI, Sommers MS, Kawut SM.

Chest. 2016 Jul;150(1):46-56. doi: 10.1016/j.chest.2016.02.633. Epub 2016 Feb 15.

10.

Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.

Ventetuolo CE, Baird GL, Barr RG, Bluemke DA, Fritz JS, Hill NS, Klinger JR, Lima JA, Ouyang P, Palevsky HI, Palmisciano AJ, Krishnan I, Pinder D, Preston IR, Roberts KE, Kawut SM.

Am J Respir Crit Care Med. 2016 May 15;193(10):1168-75. doi: 10.1164/rccm.201509-1785OC.

11.

Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.

Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM; ASA-STAT Study Group.

Ann Am Thorac Soc. 2016 Jan;13(1):25-30. doi: 10.1513/AnnalsATS.201508-543OC.

12.

Recurrent Bleeding, Survival, and Longitudinal Pulmonary Function following Bronchial Artery Embolization for Hemoptysis in a U.S. Adult Population.

Tom LM, Palevsky HI, Holsclaw DS, Trerotola SO, Dagli M, Mondschein JI, Stavropoulos SW, Soulen MC, Clark TW.

J Vasc Interv Radiol. 2015 Dec;26(12):1806-13.e1. doi: 10.1016/j.jvir.2015.08.019. Epub 2015 Oct 9.

PMID:
26481824
13.

Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.

Matura LA, Ventetuolo CE, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Pinder D, Archer-Chicko C, Bagiella E, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Kawut SM.

Ann Am Thorac Soc. 2015 Mar;12(3):370-5. doi: 10.1513/AnnalsATS.201410-463OC.

14.

Erythropoietin upregulation in pulmonary arterial hypertension.

Karamanian VA, Harhay M, Grant GR, Palevsky HI, Grizzle WE, Zamanian RT, Ihida-Stansbury K, Taichman DB, Kawut SM, Jones PL.

Pulm Circ. 2014 Jun;4(2):269-79. doi: 10.1086/675990.

15.

Are hemodynamics surrogate end points in pulmonary arterial hypertension?

Ventetuolo CE, Gabler NB, Fritz JS, Smith KA, Palevsky HI, Klinger JR, Halpern SD, Kawut SM.

Circulation. 2014 Aug 26;130(9):768-75. doi: 10.1161/CIRCULATIONAHA.114.009690. Epub 2014 Jun 20.

16.

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.

Taichman DB, Ornelas J, Chung L, Klinger JR, Lewis S, Mandel J, Palevsky HI, Rich S, Sood N, Rosenzweig EB, Trow TK, Yung R, Elliott CG, Badesch DB.

Chest. 2014 Aug;146(2):449-475. doi: 10.1378/chest.14-0793. Review.

17.

Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.

Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V.

Am Heart J. 2014 Feb;167(2):218-225.e1. doi: 10.1016/j.ahj.2013.08.008. Epub 2013 Oct 16.

18.

Pulmonary arterial hypertension related to connective tissue disease: a review.

Ahmed S, Palevsky HI.

Rheum Dis Clin North Am. 2014 Feb;40(1):103-24. doi: 10.1016/j.rdc.2013.10.001. Review.

PMID:
24268012
19.

Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.

McLaughlin VV, Palevsky HI.

Clin Chest Med. 2013 Dec;34(4):825-40. doi: 10.1016/j.ccm.2013.09.003. Epub 2013 Oct 18. Review.

PMID:
24267307
20.

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost.

Channick RN, Frantz RP, Kawut SM, Palevsky H, Tumuluri R, Sulica R, Lauto PO, Benton WW, de Boisblanc B.

Pulm Circ. 2013 Apr;3(2):381-8. doi: 10.4103/2045-8932.114768.

21.

Sex and haemodynamics in pulmonary arterial hypertension.

Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM.

Eur Respir J. 2014 Feb;43(2):523-30. doi: 10.1183/09031936.00027613. Epub 2013 Aug 15.

22.

Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials.

Gabler NB, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD.

Circulation. 2012 Jul 17;126(3):349-56. doi: 10.1161/CIRCULATIONAHA.112.105890. Epub 2012 Jun 13.

23.

Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.

Carroll R, Antigua J, Taichman D, Palevsky H, Forfia P, Kawut S, Halpern SD.

Clin Trials. 2012 Jun;9(3):348-57. doi: 10.1177/1740774512438981. Epub 2012 Mar 2.

24.

Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.

John J, Palevsky H.

Expert Rev Clin Pharmacol. 2011 Mar;4(2):197-205. doi: 10.1586/ecp.10.136. Review.

PMID:
22115402
25.

Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, Kawut SM, Halpern SD.

Chest. 2012 Jan;141(1):20-26. doi: 10.1378/chest.11-0404. Epub 2011 Sep 22.

26.

The early diagnosis of pulmonary arterial hypertension: can we do better?

Palevsky HI.

Chest. 2011 Jul;140(1):4-6. doi: 10.1378/chest.11-1149. No abstract available.

PMID:
21729886
27.

Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT.

Kawut SM, Bagiella E, Lederer DJ, Shimbo D, Horn EM, Roberts KE, Hill NS, Barr RG, Rosenzweig EB, Post W, Tracy RP, Palevsky HI, Hassoun PM, Girgis RE; ASA-STAT Study Group.

Circulation. 2011 Jun 28;123(25):2985-93. doi: 10.1161/CIRCULATIONAHA.110.015693. Epub 2011 May 18.

28.

Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension.

Arkles JS, Opotowsky AR, Ojeda J, Rogers F, Liu T, Prassana V, Marzec L, Palevsky HI, Ferrari VA, Forfia PR.

Am J Respir Crit Care Med. 2011 Jan 15;183(2):268-76. doi: 10.1164/rccm.201004-0601OC. Epub 2010 Aug 13.

PMID:
20709819
29.

Testing low-risk patients for suspected pulmonary embolism: a decision analysis.

Lessler AL, Isserman JA, Agarwal R, Palevsky HI, Pines JM.

Ann Emerg Med. 2010 Apr;55(4):316-326.e1. doi: 10.1016/j.annemergmed.2009.12.001. Epub 2010 Jan 12.

PMID:
20061065
30.

Long-term outcomes in pulmonary arterial hypertension.

Thenappan T, Palevsky HI.

Int J Clin Pract Suppl. 2009 Sep;(162):42-4. doi: 10.1111/j.1742-1241.2009.02128.x. No abstract available.

PMID:
19624799
31.

Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension.

Taichman DB, McGoon MD, Harhay MO, Archer-Chicko C, Sager JS, Murugappan M, Chakinali MM, Palevsky HI, Gallop R.

Mayo Clin Proc. 2009 Jul;84(7):586-92. doi: 10.1016/S0025-6196(11)60747-7.

32.

Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.

Zlupko M, Harhay MO, Gallop R, Shin J, Archer-Chicko C, Patel R, Palevsky HI, Taichman DB.

Respir Med. 2008 Oct;102(10):1431-8. doi: 10.1016/j.rmed.2008.04.016. Epub 2008 Jul 9.

33.

Standard therapies for pulmonary arterial hypertension.

Alam S, Palevsky HI.

Clin Chest Med. 2007 Mar;28(1):91-115, viii. Review.

PMID:
17338930
34.

Hemodynamics and survival of patients with portopulmonary hypertension.

Kawut SM, Taichman DB, Ahya VN, Kaplan S, Archer-Chicko CL, Kimmel SE, Palevsky HI.

Liver Transpl. 2005 Sep;11(9):1107-11.

35.

Health-related quality of life in patients with pulmonary arterial hypertension.

Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, Gallop R, Christie J, Hansen-Flaschen J, Palevsky H.

Respir Res. 2005 Aug 10;6:92.

36.

Validation of a brief telephone battery for neurocognitive assessment of patients with pulmonary arterial hypertension.

Taichman DB, Christie J, Biester R, Mortensen J, White J, Kaplan S, Hansen-Flaschen J, Palevsky HI, Elliott CG, Hopkins RO.

Respir Res. 2005 Apr 25;6:39.

37.

Surrogate end points for pulmonary arterial hypertension.

Kawut SM, Palevsky HI.

Am Heart J. 2004 Oct;148(4):559-65.

PMID:
15459583
38.

New answers raise new questions in pulmonary arterial hypertension.

Kawut SM, Palevsky HI.

Eur Respir J. 2004 Jun;23(6):799-801. No abstract available.

40.

Scintigraphic diagnosis of a right to left shunt in end-stage lung disease.

Graves MW, Kiratli PO, Mozley D, Palevsky H, Zukerberg B, Alavi A.

Respir Med. 2003 May;97(5):549-54.

41.

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.

Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE.

Chest. 2003 Feb;123(2):344-50.

PMID:
12576350
42.

Pulmonary ventilation and perfusion scanning using hyperpolarized helium-3 MRI and arterial spin tagging in healthy normal subjects and in pulmonary embolism and orthotopic lung transplant patients.

Lipson DA, Roberts DA, Hansen-Flaschen J, Gentile TR, Jones G, Thompson A, Dimitrov IE, Palevsky HI, Leigh JS, Schnall M, Rizi RR.

Magn Reson Med. 2002 Jun;47(6):1073-6.

43.

Alternatives to lung transplantation: lung volume reduction surgery and continuous intravenous prostacyclin.

Lipson DA, Edelman JD, Palevsky HI.

Transplant Proc. 2002 Jun;34(4):1283-6. Review. No abstract available.

PMID:
12072342
44.

Bronchogenic carcinoma complicating lung transplantation.

Arcasoy SM, Hersh C, Christie JD, Zisman D, Pochettino A, Rosengard BR, Blumenthal NP, Palevsky HI, Bavaria JE, Kotloff RM.

J Heart Lung Transplant. 2001 Oct;20(10):1044-53.

PMID:
11595559
45.

Subcutaneous phaeohyphomycotic cysts caused by Exophiala jeanselmei in a lung transplant patient.

Xu X, Low DW, Palevsky HI, Elenitsas R.

Dermatol Surg. 2001 Apr;27(4):343-6.

PMID:
11298703
46.

Recreational use of aminorex and pulmonary hypertension.

Gaine SP, Rubin LJ, Kmetzo JJ, Palevsky HI, Traill TA.

Chest. 2000 Nov;118(5):1496-7.

PMID:
11083709
47.

Fatal hyperammonemia after orthotopic lung transplantation.

Lichtenstein GR, Yang YX, Nunes FA, Lewis JD, Tuchman M, Tino G, Kaiser LR, Palevsky HI, Kotloff RM, Furth EE, Bavaria JE, Stecker MM, Kaplan P, Berry GT.

Ann Intern Med. 2000 Feb 15;132(4):283-7.

PMID:
10681283
48.

Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings.

Choi JK, Kearns J, Palevsky HI, Montone KT, Kaiser LR, Zmijewski CM, Tomaszewski JE.

Am J Respir Crit Care Med. 1999 Sep;160(3):1015-8.

PMID:
10471633
49.

Pulmonary hypertension in collagen vascular disease.

Palevsky HI, Gurughagavatula I.

Compr Ther. 1999 Mar;25(3):133-43. Review.

PMID:
10200902
50.

Extrinsic compression of the left main coronary artery by the pulmonary artery in patients with long-standing pulmonary hypertension.

Kawut SM, Silvestry FE, Ferrari VA, DeNofrio D, Axel L, Loh E, Palevsky HI.

Am J Cardiol. 1999 Mar 15;83(6):984-6, A10.

PMID:
10190427

Supplemental Content

Loading ...
Support Center